(19)
(11) EP 2 986 338 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.12.2021 Bulletin 2021/50

(45) Mention of the grant of the patent:
06.10.2021 Bulletin 2021/40

(21) Application number: 14785014.3

(22) Date of filing: 15.04.2014
(51) International Patent Classification (IPC): 
A61N 1/08(2006.01)
A61N 1/36(2006.01)
G06F 3/01(2006.01)
 A61B 5/00(2006.01)
G06F 1/16(2006.01)
A61N 1/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/4815; A61N 1/36021; A61N 1/0492; A61B 5/4836; G06F 1/1694; G06F 1/163; A61N 1/3603; A61N 1/0456; A61B 2562/0219; G06F 3/017; A61B 5/4824
(86) International application number:
PCT/US2014/034233
(87) International publication number:
WO 2014/172381 (23.10.2014 Gazette 2014/43)

(54)

TRANSCUTANEOUS ELECTRICAL NERVES STIMULATOR WITH AUTOMATIC DETECTION OF USER SLEEP-WAKE STATE

TRANSKUTANER ELEKTRISCHER NERVENSTIMULATOR MIT AUTOMATISCHER ERKENNUNG DES SCHLAF-/WACHZUSTANDS EINES BENUTZERS

STIMULATEUR DE NERF ELECTRIQUE TRANSCUTANE A DETECTION AUTOMATIQUE D'ETAT DE VEILLE-SOMMEIL

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.04.2013 US 201361811864 P
31.03.2014 US 201414230648

(43) Date of publication of application:
24.02.2016 Bulletin 2016/08

(73) Proprietor: GSK Consumer Healthcare SARL
1260 Nyon (CH)

(72) Inventors:
  • GOZANI, Shai
    Brookline, MA 02446 (US)
  • KONG, Xuan
    Acton, MA 01720 (US)
  • FERREE, Tom
    Waltham, MA 02451 (US)

(74) Representative: Gundel, Isabelle et al
GlaxoSmithKline Global Patents CN925.1 980 Great West Road
Brentford, Middlesex, TW8 9GS
Brentford, Middlesex, TW8 9GS (GB)


(56) References cited: : 
WO-A1-2012/116407
WO-A2-03/051453
US-A1- 2010 057 149
US-A1- 2013 158 627
 WO-A2-03/051453
US-A1- 2005 080 463
US-A1- 2011 282 164
US-A1- 2013 158 627
   
  • None
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).